IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sofinnova Management VIII, L.L.C.

Q3 2017 Holdings

Filed 2017-10-11 | 8 holdings | $39.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)Common Stock00461U105$39.7M1,539,48099.7%
Spark Therapeutics, Inc.Common Stock84652J103$42.9K481,2700.1%
ObsEva SACommon StockH5861P103$30.5K3,749,6230.1%
Natera, Inc.(NTRA)Common Stock632307104$20.0K1,550,2800.1%
NuCana plcAmerican Depositary Shares67022C106$12.2K666,6660.0%
Synlogic, Inc.Common Stock87166L100$8.1K424,9720.0%
Auris Medical Holding AGCommon SharesH03579101$6.4K7,818,1750.0%
Histogenics CorporationCommon Stock43358V109$4.1K2,077,0400.0%